Showing results (141-150 of 160) with videos related to

Sort By:
Pageof 16
Cancer Medicine|March 17, 2022
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer studyDominik A Barth, Stefanie Stanzer, Jasmin Spiegelberg, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2025
Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncologyDamian T Rieke, Michael Bitzer, Annalen Bleckmann, et al.
Cancers|August 23, 2020
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center StudyJakob M Riedl, Dominik A Barth, Wolfgang M Brueckl, et al.
Oncoimmunology|March 25, 2021
Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcomaMaria A Smolle, Laurin Herbsthofer, Mark Goda, et al.
International Journal of Cancer|September 9, 2025
Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATEKarin Potthoff, Jens Uhlig, Lutz Jacobasch, et al.
Frontiers in Immunology|April 18, 2022
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer StudyDominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, et al.
Thrombosis and Haemostasis|July 13, 2021
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-PaclitaxelJakob M Riedl, Esther Schwarzenbacher, Florian Moik, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2018
Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methodsMaria A Smolle, Veroniek M van Praag, Florian Posch, et al.
Nature Communications|April 22, 2020
Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detectionPeter Ulz, Samantha Perakis, Qing Zhou, et al.
Clinical Genitourinary Cancer|April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score AnalysisFranziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
Pageof 16